| Trial ID: | L0829 |
| Source ID: | NCT03073343
|
| Associated Drug: |
Betaine
|
| Title: |
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) and Elevated Alanine Aminotransferase (ALT)
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease;Non Insulin Dependent Diabetes;ALT
|
| Interventions: |
Dietary Supplement: Betaine (trimethyglycine)
|
| Outcome Measures: |
Change in alanine aminotransferase (ALT) level in all study participantsCompare changes in alanine aminotransferase (ALT) level in both cohorts
|
| Sponsor/Collaborators: |
Southern California Institute for Research and Education
|
| Gender: |
All
|
| Age: |
18 Years75 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
48
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
20/02/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03073343
|
